User:Mr. Ibrahem/Ticagrelor

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Ticagrelor
Clinical data
Trade namesBrilinta, Brilique, others
Other namesAZD-6140
AHFS/Drugs.comMonograph
MedlinePlusa611050
License data
Pregnancy
category
  • AU: B1
Routes of
administration
By mouth
Drug classAdenosine diphosphate receptor inhibitor[1]
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: ℞-only
  • EU: Rx-only
Pharmacokinetic data
Bioavailability36%
Protein binding>99.7%
MetabolismLiver (CYP3A4)
Elimination half-life7 hrs (ticagrelor), 8.5 hrs (active metabolite AR-C124910XX)
ExcretionBile duct
Identifiers
  • (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)- 3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Chemical and physical data
FormulaC23H28F2N6O4S
Molar mass522.57 g·mol−1
3D model (JSmol)
  • CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F
  • InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1 ☒N
  • Key:OEKWJQXRCDYSHL-FNOIDJSQSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Ticagrelor, sold under the brand name Brilinta among others, is a medication used in acute coronary syndrome to prevent stroke and heart attacks.[2][3] It is generally used with aspirin.[2] It is taken by mouth.[2]

Common side effects include bleeding and shortness of breath.[2] Other side effects may include cough, diarrhea, and low blood pressure.[3] It is a platelet aggregation inhibitor, specifically a adenosine diphosphate receptor inhibitor, which works by blocking ADP from attaching to platelets.[2][1]

Ticagrelor was approved for medical use in Europe 2010,[2] and in the United States in 2011.[3] In the United Kingdom 4 weeks of medication costs the NHS about £55 as of 2021.[1] In the United States this amount costs about 380 USD as of 2021.[4]

References[edit]

  1. ^ a b c BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 229. ISBN 978-0-85711-369-6.{{cite book}}: CS1 maint: date format (link)
  2. ^ a b c d e f g h "Brilique". Archived from the original on 2 May 2021. Retrieved 3 October 2021.
  3. ^ a b c d "Ticagrelor Monograph for Professionals". Drugs.com. Archived from the original on 17 September 2020. Retrieved 3 October 2021.
  4. ^ "Brilinta Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 5 November 2016. Retrieved 3 October 2021.